Osawa, Itsuki
Doi, Kent
Article History
Received: 4 August 2023
Accepted: 7 August 2023
First Online: 25 August 2023
Declarations
:
: The study protocol entitled "Targeted therapy using Polymyxin B hemadsorption in patients with sepsis" was approved by the Institutional Review Board of the University of Tokyo Hospital (No. 2022332NI) on February 27, 2023. This study was a secondary data analysis of de-identified data, and therefore, the requirement for informed consent was waived.
: Not applicable.
: The authors declare that they have no competing interests.